These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27619843)

  • 1. Does Competition Have an Effect on Price and Quality in Physiotherapy?
    Pekola P; Linnosmaa I; Mikkola H
    Health Econ; 2017 Oct; 26(10):1278-1290. PubMed ID: 27619843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition and quality in a physiotherapy market with fixed prices.
    Pekola P; Linnosmaa I; Mikkola H
    Eur J Health Econ; 2017 Jan; 18(1):97-117. PubMed ID: 27037838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effects of price regulation and freedom of choice on quality: evidence from the physiotherapy market.
    Pekola P; Linnosmaa I; Mikkola H
    Health Econ Rev; 2017 Dec; 7(1):25. PubMed ID: 28646287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health insurance and imperfect competition in the health care market.
    Vaithianathan R
    J Health Econ; 2006 Nov; 25(6):1193-202. PubMed ID: 16647770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk, high reward? Repeated competitive biddings with multiple winners in health care.
    Pitkänen V; Jauhiainen S; Linnosmaa I
    Eur J Health Econ; 2020 Jun; 21(4):483-500. PubMed ID: 31902025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Market competition, ownership, payment systems and the performance of health care providers - a panel study among Finnish occupational health services providers.
    Kankaanpää E; Linnosmaa I; Valtonen H
    Health Econ Policy Law; 2013 Oct; 8(4):477-510. PubMed ID: 23057868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice, quality and patients' experience: evidence from a Finnish physiotherapy service.
    Pitkänen V; Linnosmaa I
    Int J Health Econ Manag; 2021 Jun; 21(2):229-245. PubMed ID: 33469804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
    Augurzky B; Göhlmann S; Gress S; Wasem J
    Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance effects of information asymmetry and economies of scope in diversified service firms.
    Nayyar PR
    Acad Manage J; 1993 Feb; 36(1):28-57. PubMed ID: 10123744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?
    Granlund D; Koksal-Ayhan MY
    Eur J Health Econ; 2015 Dec; 16(9):969-83. PubMed ID: 25404013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of competition on the relationship between the introduction of the DRG system and quality of care in Korea.
    Kim SJ; Park EC; Kim SJ; Han KT; Han E; Jang SI; Kim TH
    Eur J Public Health; 2016 Feb; 26(1):42-7. PubMed ID: 26370438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital and Health Insurance Markets Concentration and Inpatient Hospital Transaction Prices in the U.S. Health Care Market.
    Dauda S
    Health Serv Res; 2018 Apr; 53(2):1203-1226. PubMed ID: 28493481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pricing and competition in the private dental market in Finland.
    Widström E; Väisänen A; Mikkola H
    Community Dent Health; 2011 Jun; 28(2):123-7. PubMed ID: 21780350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition and the Reference Pricing Scheme for pharmaceuticals.
    Ghislandi S
    J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality competition in local hospital markets: some econometric evidence from the period 1982-1988.
    Chirikos TN
    Soc Sci Med; 1992 May; 34(9):1011-21. PubMed ID: 1631601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition and efficiency in repeated procurements: Lessons from the Finnish rehabilitation markets.
    Pitkänen V
    Health Econ; 2022 May; 31(5):820-835. PubMed ID: 35187744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital pricing: cost shifting and competition.
    Morrisey MA
    EBRI Issue Brief; 1993 May; (137):1-17. PubMed ID: 10129621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The price of placements in residential and nursing home care: the effects of contracts and competition.
    Forder J; Netten A
    Health Econ; 2000 Oct; 9(7):643-57. PubMed ID: 11103930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional regulators in health care service under quality competition: A game theoretical model.
    Bisceglia M; Cellini R; Grilli L
    Health Econ; 2018 Nov; 27(11):1821-1842. PubMed ID: 30044027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.